Clinical Trial Update: A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension [Phase 4]

View source ↗

Summary

Final results from a Phase IV study of a fixed-dose combination of travoprost and brinzolamide for glaucoma or ocular hypertension have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Brinzolamide (Brinzolamide)
• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2010-03-11